Now that Baycol (cerivastatin) is off the market, patients are asking whether the other statins are safer.
September 2001
Now that Baycol (cerivastatin) is off the market, patients are asking whether the other statins are safer.
The answer is yes.
The incidence of serious rhabdomyolysis was almost 10 times higher with Baycol than the other statins.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote